Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02656784
Other study ID # UESPI
Secondary ID
Status Completed
Phase N/A
First received December 5, 2015
Last updated June 21, 2017
Start date February 2015
Est. completion date May 3, 2017

Study information

Verified date June 2017
Source Universidade Estadual do PiauÍ
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a sample made up of ninety-six adult individuals of both sexes to be divided into three groups: the experimental group of thirty-two patients with OCD who will be undergone Trial-Based Cognitive Therapy; the gold standard, with thirty-two people with OCD subject Exposure and Response Prevention and the control group of thirty-two healthy individuals. Interviews and therapeutic intervention occur in private practices researchers or medical schools accredited by UESPI.

Experimental group: Will be eligible adults of both sexes with educational level equal to or higher education complete primary, aged between 18 and 60 years with OCD diagnosis confirmed according to criteria DSM-IV (APA, 1994). It is going to be excluded patients who had previously undergone treatment behavioral psychotherapy or cognitive-behavioral approach.


Description:

OBJECTIVES

Evaluate the effectiveness of Trial-Based Cognitive Therapy (TBCT) compared to Exposure and Response Prevention (ERP) in the treatment of OCD patients, by neuroimaging tests such as MRI.

1. Describe the neuroanatomical profile of the sample participants before and after the psychotherapeutic intervention by MRI;

2. Compare the profile neuroanatomical between the experimental group and the control group by MRI;

3. Identify possible neuroanatomical differences in the participating sample of pre and post-treatment, both among individuals and among psychotherapeutic intervention groups;

4. To investigate associations between the results of MRI scans and indexes the scales currently used to assess severity of OCD.


Recruitment information / eligibility

Status Completed
Enrollment 96
Est. completion date May 3, 2017
Est. primary completion date December 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Will be eligible adults of both sexes with educational level equal to or higher education complete primary, aged between 18 and 60 years with OCD diagnosis confirmed according to criteria DSM-IV

Exclusion Criteria:

- It is going to be excluded patients who had previously undergone treatment behavioral psychotherapy or cognitive-behavioral approach.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive Therapy
Trial-Based Cognitive Therapy (TBCT) is a three-level, three-phase, case formulation approach. TBCT's foundation is in cognitive therapy (CT); however, it has a unique approach to conceptualization and techniques that make it a distinct intervention in modifying patients' core beliefs, especially those about the self. All the individuals will be submitted to MRI.
Behavioral Therapy
The Behavioral therapy employs the technique of Exposure and Response Prevention ( ERP ).The technique involves directly exposing patients to recall stimulation of obsessive thoughts and prevent them from performing the compulsive rituals. All the individuals will be submitted to MRI.

Locations

Country Name City State
Brazil Piauí State University - UESPI Teresina Piauí

Sponsors (2)

Lead Sponsor Collaborator
Universidade Estadual do PiauÍ Federal University of Bahia

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary The severity of OCD (Morphological and physiological changes in the brain) Data colected at 1st week, 6th week, 12th week. Scales used are Yale-Brown Obssessive Compulsive Scale and Symptoms of Checklist (Y-BOCS), Beck Depression Inventory (BDI), Beck Anxienty Inventory (BAI), Obsessive-Compulsive Beliefs Questionnaire-87 (OBQ-87), The Medical Outcomes Study 36 - Item Short Form Health Survery ( SF-36), Questionnare of Cognitive Distortions (CD-Quest), Subjective Units of Discomfort (SUDS) and MRI. 12 weeks (3 months)
Secondary Quality of Life Data colected at 1st week and 12th week and, at follow-up, after three months, six months and one year. The scale used is SF-36 12 weeks
Secondary Quality of Life At follow-up, after three months, six months and one year. The scale used is SF-36 1 year
Secondary Cognitive Distortions Data colected every week (during 12 weeks). The scale used is CD-Quest 12 weeks
Secondary Cognitive Distortions At follow-up, after three months, six months and one year. The scale used is Cognitive Distortions Questionnaire. 1 year
Secondary Severity of OCD Data colected at 1st week, 6th week and 12th week and, at follow-up, after three months, six months and one year. The scale used is Y-BOCS 12 weeks
Secondary Severity of OCD At follow-up, after three months, six months and one year. The scale used is Y-BOCS. 1 year
Secondary The Assessment of Depression Data colected at 1st week, 6th week and 12th week and, at follow-up, after three months, six months and one year. The scale used is BDI 12 weeks
Secondary The Assessment of Depression At follow-up, after three months, six months and one year. The scale used is BDI 1 year
Secondary The Assessment of Anxiety Data colected at 1st week, 6th week and 12th week and, at follow-up, after three months, six months and one year. The scale used is BAI 12 weeks
Secondary The Assessment of Anxiety At follow-up, after three months, six months and one year. The scale used is BAI 1 year
Secondary The Assessment of Magnetic Resonance (MRI) Data colected at zero week and 15th week. The scale used is MRI 15 weeks
Secondary The Assessment of The Obssessive Beliefs Data colected at zero week and 15th week. The scale used is OBQ-87 15 weeks
Secondary The level of Anxiety (Obssessive, Compulsive and Evitation Symptoms) Data colected every week (during 12 weeks). The scale used is SUDS 12 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02886780 - "Concentrated Exposure Treatment" (cET) for for Obsessive Compulsive Disorder N/A
Completed NCT00525226 - Evaluating the Effects of Stress in Pregnancy N/A
Recruiting NCT05240924 - ERP to Improve Functioning in Veterans With OCD N/A
Completed NCT03476902 - Feasibility, Acceptability, and Preliminary Efficacy of a Mobile App (nOCD) for OCD N/A
Completed NCT01617083 - Antibiotic Treatment Trial for the PANDAS/PANS Phenotype Phase 2
Completed NCT01447966 - Family Based Cognitive-Behavioral Treatment for Preschoolers With Obsessive Compulsive Disorder N/A
Recruiting NCT02528331 - Cognitive Behavioral Strategies and Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder: Open Label Study N/A
Completed NCT04432246 - Electroencephalography Predictors of Repetitive Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder N/A
Not yet recruiting NCT02160431 - Neuropsychological Profiles of Pediatric Obsessive Compulsive Disorder (OCD) N/A
Recruiting NCT01879254 - Long-term Follow-up in Patients With Deep Brain Stimulation (DBS) for Obsessive Compulsive Disorder (OCD). N/A
Completed NCT00216294 - Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder Phase 2
Active, not recruiting NCT02216981 - Examining the Feasibility and Acceptability of Good Quality Intensive CBT for OCD and Good Quality Weekly CBT for OCD N/A
Recruiting NCT05160129 - Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder N/A